Caption Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Hold |
0
| – | – | – | 566 |
|
|
2025
Q1 | – | Hold |
0
| – | – | – | 593 |
|
|
2024
Q4 | – | Sell |
-27,300
| Closed | -$1.92M | – | 572 |
|
|
2024
Q3 | $1.92M | Buy |
+27,300
| New | +$1.92M | 0.03% | 99 |
|
|
2024
Q2 | – | Sell |
-22,929
| Closed | -$2M | – | 457 |
|
|
2024
Q1 | $2M | Buy |
22,929
+9,649
| +73% | +$843K | 0.03% | 86 |
|
|
2023
Q4 | $1.28M | Buy |
+13,280
| New | +$1.28M | 0.02% | 135 |
|
|
2023
Q3 | – | Sell |
-113,872
| Closed | -$9.87M | – | 473 |
|
|
2023
Q2 | $9.87M | Buy |
113,872
+83,872
| +280% | +$7.27M | 0.17% | 14 |
|
|
2023
Q1 | $2.92M | Buy |
+30,000
| New | +$2.92M | 0.06% | 39 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 486 |
|
|
2022
Q3 | – | Sell |
-19,495
| Closed | -$1.62M | – | 559 |
|
|
2022
Q2 | $1.62M | Buy |
19,495
+3,090
| +19% | +$256K | 0.02% | 134 |
|
|
2022
Q1 | $1.26M | Buy |
+16,405
| New | +$1.26M | 0.02% | 212 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 607 |
|
|
2021
Q2 | – | Sell |
-25,399
| Closed | -$1.92M | – | 461 |
|
|
2021
Q1 | $1.92M | Buy |
25,399
+24,997
| +6,218% | +$1.89M | 0.04% | 110 |
|
|
2020
Q4 | $35K | Sell |
402
-29,898
| -99% | -$2.6M | ﹤0.01% | 286 |
|
|
2020
Q3 | $2.31M | Sell |
30,300
-36,688
| -55% | -$2.79M | 0.05% | 61 |
|
|
2020
Q2 | $8.26M | Buy |
+66,988
| New | +$8.26M | 0.28% | 8 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 349 |
|
|
2019
Q4 | – | Sell |
-4,000
| Closed | -$269K | – | 319 |
|
|
2019
Q3 | $269K | Sell |
4,000
-12,500
| -76% | -$841K | 0.01% | 175 |
|
|
2019
Q2 | $1.41M | Sell |
16,500
-6,100
| -27% | -$523K | 0.07% | 62 |
|
|
2019
Q1 | $2.01M | Buy |
+22,600
| New | +$2.01M | 0.11% | 39 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 216 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 222 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 171 |
|
|
2018
Q1 | – | Sell |
-25,000
| Closed | -$2.23M | – | 105 |
|
|
2017
Q4 | $2.23M | Buy |
+25,000
| New | +$2.23M | 0.23% | 20 |
|